NOS2 and Alzheimer disease: The CVN-AD mouse model is a bigenic line that incorporates the hAPP transgene with the Swedish, Iowa (D694) and E693Q mutations, under the control of the Thy1 promoter, with mouse nitric oxide synthase (NOS2) knocked-out.